IC
SBBP

Ikarian Capital’s Strongbridge Biopharma plc. SBBP Stock Holding History

Ikarian Capital’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,160,450
Closed -$3.2M – 319
2021
Q1 		$3.2M Sell
1,160,450
-1,279,578
-52% -$3.86M 0.11% 167
2020
Q4 		$5.93M Sell
2,440,028
-922,214
-27% -$2.22M 0.26% 85
2020
Q3 		$7.06M Buy
3,362,242
+91,004
+3% +$307K 0.51% 49
2020
Q2 		$12.4M Sell
3,271,238
-121,549
-4% -$364K 0.98% 32
2020
Q1 		$6.41M Buy
+3,392,787
New +$8.82M 0.48% 52

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ikarian Capital's SBBP Position: Q2 2021 in Review

Ikarian Capital sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 1,160,450 shares — an estimated $3.2M sold.

Ikarian Capital first reported a position in SBBP in Q1 2020 and held it in 5 quarters. The position peaked at $12.4M in Q2 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Ikarian Capital reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Ikarian Capital sold 1,160,450 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $3.2M.
  • Ikarian Capital first reported a position in Strongbridge Biopharma plc. in Q1 2020 and held it in 5 quarters.
  • Ikarian Capital's Strongbridge Biopharma plc. position peaked at $12.4M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.